<?xml version="1.0" encoding="UTF-8"?>
<ref id="b0045">
 <label>9</label>
 <element-citation publication-type="journal" id="h0045">
  <person-group person-group-type="author">
   <name>
    <surname>Sparrow</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Torvaldsen</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Newall</surname>
    <given-names>A.T.</given-names>
   </name>
   <name>
    <surname>Wood</surname>
    <given-names>J.G.</given-names>
   </name>
   <name>
    <surname>Sheikh</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Kieny</surname>
    <given-names>M.P.</given-names>
   </name>
  </person-group>
  <article-title>Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: a review of the current status of the clinical development pipeline</article-title>
  <source>Vaccine</source>
  <volume>37</volume>
  <year>2019</year>
  <fpage>A132</fpage>
  <lpage>A139</lpage>
  <pub-id pub-id-type="pmid">30503659</pub-id>
 </element-citation>
</ref>
